연구물
17건 검색
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Interim outcomes of delamanid for the treatment of MDR- and XDR-TB in South Korea
- 연구출판물 · 기타JCR Q1Scopus Q1Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or Delamanid
Hwang, HyeontaekKang, HyungseokKwon, Yong-Soo전두수Shim, Tae Sun외 1명
- 연구출판물 · 기타JCR Q2Scopus Q1Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB
Chung, C.Shin, J. E.전두수Kang, H.Yim, J-J.외 2명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea
Kang, HyungseokJo, Kyung-Wook전두수Yim, Jae-JoonShim, Tae Sun
- 연구출판물 · 학술지 논문JCR Q1Scopus Q2A Prospective Cohort Study on the Usage, Safety, and Efficacy of Delamanid in Patients With Pulmonary Multidrug-Resistant Tuberculosis in South Korea
목정하Seo, HaesookCho, YoungsooLee, TaehoonKim, Sang-Ha외 3명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid
Lee, Hoon HeeJo, Kyung-WookYim, Jae-Joon전두수Kang, Hyungseok외 1명
- 연구출판물 · 기타JCR Q2Scopus Q2KCI Q2Treatment Outcomes of Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid - Authors’ Reply
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process
- 연구출판물 · 기타JCR Q1Scopus Q1Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea
Kwon, Yong-Soo전두수Kang, HyungseokYim, Jae-JoonShim, Tae Sun
- 연구출판물 · 학술지 논문JCR Q1Scopus Q19 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
- 연구출판물 · 학술지 논문JCR Q1Scopus Q2Compliance with new drug use and the effect of discrepant drug susceptibility testing on MDR/RR-TB treatment
- 연구출판물 · 학술지 논문JCR Q3Scopus Q1KCI Q2Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis
Carroll, Matthew W.Jeon, DoosooMountz, James M.Lee, Jong Doo정연주외 20명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Treatment outcomes of multidrug-resistant TB with selective use of new drugs
Kwon, Y-S.Shin, J. E.Kang, H.전두수Yim, J-J.외 1명
- 연구출판물 · 학술지 논문Scopus Q2KCI Q1Treatment outcomes of patients with multidrug-resistant tuberculosis: Comparison of pre- And post-public–Private mix periods



로그인
홈
Researcher Page
ISNI
ORCID